Clinical Trial Update: A Study to Determine the Best Dose of Antivirals in Patients With Both TB and HIV [Phase 4]

View source ↗

Summary

A Phase 4 trial to identify the optimal antiviral dose for patients co-infected with tuberculosis and HIV has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Tuberculosis

Snippet

Sponsor: Stanford University | Conditions: HIV Infections, Tuberculosis | Phase 4 | Status: TERMINATED